- Clinical use of DPP-4 inhibitors2012 | Second Faculty of Medicine
- Inhibitors of DPP-4 and cardiovascular effects2016 | Faculty of Medicine in Pilsen
- Comparison of clinical efficacy of DPP-4 inhibitors sitagliptin and vildagliptin2009 | Second Faculty of Medicine
- DPP-4 inhibitors and autoimmunity2014 | First Faculty of Medicine, Third Faculty of Medicine
- Selectivity of DPP-4 inhibitors and heart failure2016 | First Faculty of Medicine
- Cardioascular effect of incretin-based therapies: comparison od DPP-4 inhibitors and GLP-1 agonists2014 | First Faculty of Medicine
- Inhibitory DPP-4 a kardiovaskulární nežádoucí účinky2017 | Publication without faculty affiliation
- Inhibitory DPP-4 a agonisté receptoru pro GLP-1 se nevzdávají2018 | Second Faculty of Medicine
- Update on therapy with dipeptidyl-peptidase 4 inhibitors2014 | Second Faculty of Medicine
- Modern treatment of diabetes in questions and responses2014 | First Faculty of Medicine
- Sitagliptin in 2012 - the current knowledge about the first DPP-4 inhibitor2012 | Second Faculty of Medicine
- Inhibitory DPP-4-gliptins: clinical practice 20102011 | Second Faculty of Medicine
- The association of antidiabetic medications and Mini-Mental State Examination scores in patients with diabetes and dementia2021 | Second Faculty of Medicine
- Linagliptin in the treatment of type 2 diabetes mellitus current status and perspectives2013 | First Faculty of Medicine
- Fixed combination of linagliptin/metformin in the treatment of type 2 diabetes mellitus2013 | First Faculty of Medicine
- Gliptins and diabetes treatment - today and in the future2011 | Faculty of Medicine in Hradec Králové
- Efficiency and safety of linagliptin - relevance to clinical practice2014 | First Faculty of Medicine
- Current role of gliptins in diabetes management2022 | Publication without faculty affiliation
- New possibilities of vildagliptin administration as part of combinations of three drugs2013 | First Faculty of Medicine
- The benefit of gliptin therapy in elderly diabetics2022 | Publication without faculty affiliation
- Commentary - Saxagliptine is non-inferior to gipizide in partients with type 2 diabetes mellitus2011 | First Faculty of Medicine
- Approach focused on the patient - the path to true individualization of diabetes2012 | First Faculty of Medicine
- Sitagliptin is safe alternative in the treatment of the light renal insuficiency2008 | Second Faculty of Medicine
- Linagliptin in the therapy of diabetes mellitus in 2012 - novelties and perspectives2012 | First Faculty of Medicine
- Vildagliptin/metformin fixed-dose combination2009 | First Faculty of Medicine
- How will diabetes treatment change with new pharmaceuticals?2015 | Second Faculty of Medicine
- Clinical efficacy of sitagliptin and vildagliptin2009 | Second Faculty of Medicine
- Co přinesl rok 2022 v diabetologii2023 | First Faculty of Medicine
- Léčba diabetu 2. typu fixní kombinací metformin/vildagliptin2022 | First Faculty of Medicine
- Single pill combination of linagliptin and metformin - case report2015 | First Faculty of Medicine